NHLBI Archives
Fishing for heart attack repair tools
Jan. 5, 2012—Managing myocardial infarction – and the resulting heart failure – remains a clinical challenge. To search for chemicals that can stimulate cardiac muscle cell production, Vanderbilt Institute of Chemical Biology investigators led by Tao Zhong, Ph.D., Terri Ni, Ph.D., and Eric Rellinger, M.D., turned to a novel drug discovery tool: zebrafish. The researchers visually screened...
Meds’ benefits differ in dialysis patients
Jan. 5, 2012—About half of kidney patients will die from heart disease within five years of starting dialysis, yet patients with kidney failure are rarely included in heart disease research. Jorge Gamboa, M.D., T. Alp Ikizler, M.D., and Nancy Brown, M.D., completed a small study that suggests a more personalized approach to selecting medication for heart disease...
Move out, cholesterol
Dec. 8, 2011—Compounds developed at Vanderbilt could offer a whole new way to treat atherosclerosis.
Lung disorder drug regimen found harmful
Oct. 31, 2011—Longtime treatment for IPF ineffective and even dangerous.
Supplements don’t help lung injury patients
Oct. 13, 2011—Supplements did not improve outcomes of patients with acute lung injury.
Gene ups risk for needing pacemaker
Apr. 1, 2011—Researchers have identified a gene that increases the risk for developing sick sinus syndrome – the most common cause for implanting a cardiac pacemaker.
Smell test tells disorders apart
Mar. 17, 2011—Patients with certain autonomic nervous system disorders have impaired odor identification, which could aid in diagnosis.
